| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/30/2003 | US20030022235 Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| 01/30/2003 | US20030022221 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | US20030022219 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of blood, kidney and nervous system disorders |
| 01/30/2003 | US20030022217 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders |
| 01/30/2003 | US20030022208 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | US20030022205 Nucleotide sequences coding membrane protein for use in the treatment of epilepsy and psychiatric disorders |
| 01/30/2003 | US20030022202 Amino acid sequences for use in the treatment of inflammation and autoimmune diseases |
| 01/30/2003 | US20030022199 Transporter genes OATP-B,C,D, and E |
| 01/30/2003 | US20030022196 Methods and compositions for screening for altered cellular phenotypes |
| 01/30/2003 | US20030022195 59914 and 59921, choline transporters and uses therefor |
| 01/30/2003 | US20030022188 Compositions and methods relating to colon specific genes and proteins |
| 01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/30/2003 | US20030022186 Novel human G-protein coupled receptor, hgprbmy18, expressed highly in pituitary gland and colon carcinoma cells |
| 01/30/2003 | US20030022185 Secreted protein HLHFP03 |
| 01/30/2003 | US20030022184 Protein for use in the diagnosis, prevention and treatment of mammary gland cancer |
| 01/30/2003 | US20030022183 Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cord |
| 01/30/2003 | US20030022181 Streptococcus pneumoniae antigens |
| 01/30/2003 | US20030022171 Detection of modulator of amyloid precursor protein cleavage; obtain cells, incubate with modulator, detect adjustment in amyloid precursor protein, adjustment in protein indicates modulator |
| 01/30/2003 | US20030022170 Nucleotide sequences coding polypeptide for use in treating wounds and tumors |
| 01/30/2003 | US20030022158 Peptide for use in the treatment of viral infection |
| 01/30/2003 | US20030021813 Essential bacteria genes and genome scanning in Haemophilus influenzae for the identification of 'essential genes' |
| 01/30/2003 | US20030021812 Genetic engineering; vaccines; induction immunology response, antibodies |
| 01/30/2003 | US20030021809 Nucleic acid expression vector |
| 01/30/2003 | US20030021807 Prevent lentivirus infections; polypeptides |
| 01/30/2003 | US20030021806 Papilloma virus capsomere vaccine formulations and method of use |
| 01/30/2003 | US20030021805 Generation of HCV-like particles and chimeric HCV virus |
| 01/30/2003 | US20030021804 Immunological process for increasing the hdl cholestrol concentration |
| 01/30/2003 | US20030021803 Transgenic plant-based vaccines |
| 01/30/2003 | US20030021802 Genetic engineering; diagnosing gastrointestinal disorders |
| 01/30/2003 | US20030021801 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
| 01/30/2003 | US20030021800 Diagnosing infections; calibration using antibodies |
| 01/30/2003 | US20030021795 Administering antibody; determination binding to peptide |
| 01/30/2003 | US20030021794 Heat shock protein-based vaccines and immunotherapies |
| 01/30/2003 | US20030021789 Infection therapy |
| 01/30/2003 | US20030021788 Novel human STRA6-like protein and nucleic acids encoding the same |
| 01/30/2003 | US20030021786 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 01/30/2003 | US20030021785 Use of rank antagonists to treat cancer |
| 01/30/2003 | US20030021776 Regulation of angiogenesis with zinc finger proteins |
| 01/30/2003 | US20030021770 Vaccines |
| 01/30/2003 | US20030021768 Viral mutants that selectively replicate in targeted human cancer cells |
| 01/30/2003 | US20030021767 Recombinant p53 adenovirus methods and compositions |
| 01/30/2003 | US20030021765 Polymer conjugates of interferon beta-1a and uses |
| 01/30/2003 | US20030021764 Methods of treatment of neurological diseases by interferon antagonists |
| 01/30/2003 | US20030019505 UV irradiation of air handlers and other apparatus |
| 01/30/2003 | CA2486593A1 Regulation of peroxisomal fatty acid transport in plants |
| 01/30/2003 | CA2454573A1 Protein and nucleic acid expression systems |
| 01/30/2003 | CA2454566A1 Phenylthiocarbamide (ptc) taste receptor |
| 01/30/2003 | CA2454548A1 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination |
| 01/30/2003 | CA2454427A1 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | CA2454423A1 Method and reagents for identifying gene targets for treating breast cancer |
| 01/30/2003 | CA2454419A1 Invasion complex and methods of targeting |
| 01/30/2003 | CA2454185A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | CA2454119A1 Nucleic acids coding for a isum2a polypeptide and use of said nucleic acids to obtain transformed plants producing seeds altered in germ development |
| 01/30/2003 | CA2453986A1 Glycoprotein vi fusion proteins |
| 01/30/2003 | CA2453967A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453965A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | CA2453655A1 Novel human proton-gated channels |
| 01/30/2003 | CA2453567A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/30/2003 | CA2453428A1 Plant ion channels and methods |
| 01/30/2003 | CA2453249A1 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | CA2452518A1 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | CA2450692A1 Tumor antigen |
| 01/29/2003 | EP1279744A2 Identification and use of molecules implicated in pain |
| 01/29/2003 | EP1279740A1 Recombinant vector derived from adeno-associated virus for gene therapy |
| 01/29/2003 | EP1279739A1 Recombinant vectors derived from adeno-associated virus expressing TAM67 for gene therapy |
| 01/29/2003 | EP1279735A1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 01/29/2003 | EP1279733A1 Nucleic acids and polypeptides involved in the predisposition to infection to human papilloma virus, to epidermodysplasia verruciformis and/or to psoriasis |
| 01/29/2003 | EP1279731A1 Process for the development of binding mini-proteins |
| 01/29/2003 | EP1279729A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors |
| 01/29/2003 | EP1279679A1 Composition containing leishmania lip2a |
| 01/29/2003 | EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions |
| 01/29/2003 | EP1279677A1 Gd3-mimetic peptides |
| 01/29/2003 | EP1279404A1 Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
| 01/29/2003 | EP1279332A2 Transgenic non-human mammal |
| 01/29/2003 | EP1279120A2 System for functional gene discovery in plants |
| 01/29/2003 | EP1278893A2 Diagnosis of diseases associated with dna replication |
| 01/29/2003 | EP1278892A1 Detection of variations in the dna methylation profile |
| 01/29/2003 | EP1278883A2 E. coli extract for protein synthesis |
| 01/29/2003 | EP1278878A2 Codon optimisation for expression in retrovirus packaging cells |
| 01/29/2003 | EP1278874A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/29/2003 | EP1278867A2 Hcv ns2/3 fragments and uses thereof |
| 01/29/2003 | EP1278856A2 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 01/29/2003 | EP1278855A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/29/2003 | EP1278854A2 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/29/2003 | EP1278853A2 Listeria monocytogenes genome, polypeptides and uses |
| 01/29/2003 | EP1278852A2 Zsig33-like peptides |
| 01/29/2003 | EP1278850A1 Edg8 receptor, its preparation and use |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278848A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 01/29/2003 | EP1278847A1 New gtpase-activating protein 1 |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278845A2 Cellular regulators of infectious agents and methods of use |
| 01/29/2003 | EP1278844A2 G protein-coupled receptors |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278841A2 G protein-coupled receptor |
| 01/29/2003 | EP1278840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278839A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |